1. Home
  2. Analysis
  3. Dexamethasone
  4. Dermatitis-exfoliative

Dexamethasone and Dermatitis exfoliative - a phase IV clinical study of FDA data

Summary:

Dermatitis exfoliative is reported as a side effect among people who take Dexamethasone (dexamethasone), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Revlimid, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Dermatitis exfoliative when taking Dexamethasone. It is created by eHealthMe based on reports of 161,257 people who have side effects when taking Dexamethasone from the FDA, and is updated regularly.

What is Dexamethasone?

Dexamethasone has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 161,927 Dexamethasone users. Check the latest studies of Dexamethasone.

What is Dermatitis exfoliative?

Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss) is found to be associated with 681 drugs and 945 conditions by eHealthMe. Check the latest studies of Dermatitis exfoliative.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

161,257 people reported to have side effects when taking Dexamethasone.
Among them, 92 people (0.06%) have Dermatitis exfoliative.

Could Dexamethasone cause Dermatitis exfoliative?

Among these 92 people:

How long have people been on Dexamethasone when they have Dermatitis exfoliative? *

  • < 1 month: 63.64 %
  • 1 - 6 months: 31.82 %
  • 6 - 12 months: 4.55 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Dermatitis exfoliative when taking Dexamethasone? *

  • female: 36.78 %
  • male: 63.22 %

What is the age of people who have Dermatitis exfoliative when taking Dexamethasone? *

  • 0-1: 0.0 %
  • 2-9: 3.7 %
  • 10-19: 1.23 %
  • 20-29: 2.47 %
  • 30-39: 1.23 %
  • 40-49: 11.11 %
  • 50-59: 24.69 %
  • 60+: 55.56 %

What are other drugs people take besides Dexamethasone? *

  1. Revlimid: 12 people, 13.04%
  2. Bactrim: 10 people, 10.87%
  3. Velcade: 10 people, 10.87%
  4. Taxotere: 9 people, 9.78%
  5. Methotrexate: 8 people, 8.70%
  6. Ranitidine: 7 people, 7.61%
  7. Allopurinol: 6 people, 6.52%
  8. Gemzar: 6 people, 6.52%
  9. Digoxin: 6 people, 6.52%
  10. Thalidomide: 6 people, 6.52%

What are other side effects people have besides Dermatitis exfoliative? *

  1. Fever: 21 people, 22.83%
  2. Rashes (redness): 13 people, 14.13%
  3. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 12 people, 13.04%
  4. Itching: 11 people, 11.96%
  5. Mucosal Inflammation (infection of mucous membrane): 9 people, 9.78%
  6. Erythema Multiforme (a type of hypersensitivity reaction): 9 people, 9.78%
  7. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 8 people, 8.70%
  8. Stomatitis (inflammation of mucous membrane of mouth): 8 people, 8.70%
  9. Diarrhea: 8 people, 8.70%
  10. Weakness: 7 people, 7.61%

What are the existing conditions these people have? *

  1. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 7 people, 7.61%
  2. Lung Cancer - Non-Small Cell (lung cancer): 4 people, 4.35%
  3. Pain: 4 people, 4.35%
  4. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 3.26%
  5. Breast Cancer: 3 people, 3.26%
  6. Nausea (feeling of having an urge to vomit): 3 people, 3.26%
  7. Insomnia (sleeplessness): 2 people, 2.17%
  8. Neurosarcoidosis (a condition of unknown cause featuring a collection of immune cells in various tissues, involving the central nervous system (brain and spinal cord)): 2 people, 2.17%
  9. Colon Cancer Metastatic (cancer of colon spreads to other part of body): 2 people, 2.17%
  10. Bladder Cancer: 2 people, 2.17%

* Approximation only. Some reports may have incomplete information.

Do you take Dexamethasone and have Dermatitis exfoliative?

- Check whether Dermatitis exfoliative is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dexamethasone:

Dermatitis exfoliative treatments and more:

How severe was Dermatitis exfoliative and when was it recovered:

Expand to all the drugs that have ingredients of dexamethasone:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dexamethasone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis exfoliative:

Browse all the conditions that are associated with Dermatitis exfoliative:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on dexamethasone (the active ingredients of Dexamethasone) and Dexamethasone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.